Adult dermatomyositis associated with NXP-2 positivity exhibits a distinctive phenotype in terms of clinical manifestations, complications, and prognosis-particularly an elevated malignancy risk-and is now regarded as an independent subset within the IIMs spectrum. Here, MORC3 is linked to dermatomyositis.